Evidence map›Paper›PMID 35123435›Full record

ArticleBMC cancer2022

Polymorphisms in autophagy genes are genetic susceptibility factors in glioblastoma development.

E Bueno-Martínez, M Lara-Almunia, C Rodríguez-Arias, A Otero-Rodríguez, S Garfias-Arjona, R González-Sarmiento

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in BMC cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Cancers · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

E Bueno-MartínezMolecular Medicine Unit, Department of Medicine, Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, University Hospital of Salamanca, Salamanca, Spain.
M Lara-AlmuniaNeurosurgery Service, Son Espases University Hospital, Mallorca, Spain.
C Rodríguez-AriasNeurosurgery Service, University Hospital of Valladolid, Valladolid, Spain.
A Otero-RodríguezNeurosurgery Service, University Hospital of Salamanca, Salamanca, Spain.
S Garfias-ArjonaNeurosurgery Service, Son Espases University Hospital, Mallorca, Spain.
R González-SarmientoMolecular Medicine Unit, Department of Medicine, Institute for Biomedical Research of Salamanca (IBSAL), Institute of Cancer Molecular and Cellular Biology (IBMCC), University of Salamanca, University of Salamanca-CSIC, 37007, Salamanca, Spain. gonzalez@usal.es.
Universidad de Salamanca · ESHospital Universitario Son Espases · ESUniversidad de Valladolid · ES

Funding

Instituto de Salud Carlos III FIS PI13/01741Ministerio de Educación, Cultura y Deporte (ES) AP2010-3728
6 · The paper itself

Abstract

backgroundGlioblastoma is the most aggressive and common malignant primary brain tumor in adults. Many genetic, epigenetic and genomic mutations have been identified in this tumor, but no driving cause has been identified yet for glioblastoma pathogenesis. Autophagy has proved to be deregulated in different diseases such as cancer where it has a dual role, acting as a tumor suppression mechanism during the first steps of tumor development and promoting cancer cells survival in stablished tumors.

methodsHere, we aimed to assess the potential association between several candidate polymorphisms in autophagy genes (ATG2B rs3759601, ATG16L1 rs2241880, ATG10 rs1864183, ATG5 rs2245214, NOD2 rs2066844 and rs2066845) and glioblastoma susceptibility.

resultsOur results showed a significant correlation between ATG2B rs3759601, ATG10 rs1864183 and NOD2 rs2066844 variants and higher risk to suffer glioblastoma. In addition, the relationship between the different clinical features listed in glioblastoma patients and candidate gene polymorphisms was also investigated, finding that ATG10 rs1864183 might be a promising prognosis factor for this tumor.

conclusionsThis is the first report evaluating the role of different variants in autophagy genes in modulating glioblastoma risk and our results emphasize the importance of autophagy in glioblastoma development.

Indexed as

AdultAgedAutophagyAutophagy-Related Protein 5Autophagy-Related ProteinsBrain NeoplasmsFemaleGenetic Predisposition to DiseaseGlioblastomaHumansMaleMiddle AgedNod2 Signaling Adaptor ProteinPolymorphism, GeneticSpainVesicular Transport ProteinsATG10 protein, humanATG16L1 protein, humanATG2B protein, humanATG5 protein, humanAutophagy-Related Protein 5Autophagy-Related ProteinsNOD2 protein, humanNod2 Signaling Adaptor ProteinVesicular Transport ProteinsATG10ATG16L1ATG2BATG5AutophagyGlioblastomaNOD2Polymorphisms

Identifiers

PMID35123435
PMCPMC8818195
OpenAlexW4210512435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.